{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:04:32Z","timestamp":1769688272647,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,25]],"date-time":"2011-12-25T00:00:00Z","timestamp":1324771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/nm.2582","type":"journal-article","created":{"date-parts":[[2011,12,25]],"date-time":"2011-12-25T18:45:30Z","timestamp":1324838730000},"page":"143-147","source":"Crossref","is-referenced-by-count":126,"title":["Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential"],"prefix":"10.1038","volume":"18","author":[{"given":"Netta","family":"Sela-Passwell","sequence":"first","affiliation":[]},{"given":"Raghavendra","family":"Kikkeri","sequence":"additional","affiliation":[]},{"given":"Orly","family":"Dym","sequence":"additional","affiliation":[]},{"given":"Haim","family":"Rozenberg","sequence":"additional","affiliation":[]},{"given":"Raanan","family":"Margalit","sequence":"additional","affiliation":[]},{"given":"Rina","family":"Arad-Yellin","sequence":"additional","affiliation":[]},{"given":"Miriam","family":"Eisenstein","sequence":"additional","affiliation":[]},{"given":"Ori","family":"Brenner","sequence":"additional","affiliation":[]},{"given":"Tsipi","family":"Shoham","sequence":"additional","affiliation":[]},{"given":"Tamar","family":"Danon","sequence":"additional","affiliation":[]},{"given":"Abraham","family":"Shanzer","sequence":"additional","affiliation":[]},{"given":"Irit","family":"Sagi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,12,25]]},"reference":[{"key":"BFnm2582_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/37995","volume":"389","author":"FX Gomis-R\u00fcth","year":"1997","unstructured":"Gomis-R\u00fcth, F.X. et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389, 77\u201381 (1997).","journal-title":"Nature"},{"key":"BFnm2582_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.biochi.2004.09.025","volume":"87","author":"P Cuniasse","year":"2005","unstructured":"Cuniasse, P. et al. Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs. Biochimie 87, 393\u2013402 (2005).","journal-title":"Biochimie"},{"key":"BFnm2582_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw, A., Ewald, A.J. & Werb, Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221\u2013233 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnm2582_CR4","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-08-3255","volume":"69","author":"L Devy","year":"2009","unstructured":"Devy, L. et al. Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion and angiogenesis. Cancer Res. 69, 1517\u20131526 (2009).","journal-title":"Cancer Res."},{"key":"BFnm2582_CR5","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1093\/emboj\/17.17.5238","volume":"17","author":"C Fernandez-Catalan","year":"1998","unstructured":"Fernandez-Catalan, C. et al. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J. 17, 5238\u20135248 (1998).","journal-title":"EMBO J."},{"key":"BFnm2582_CR6","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1021\/bi902141x","volume":"49","author":"M Grossman","year":"2010","unstructured":"Grossman, M. et al. The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function. Biochemistry 49, 6184\u20136192 (2010).","journal-title":"Biochemistry"},{"key":"BFnm2582_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","volume":"69","author":"H Nagase","year":"2006","unstructured":"Nagase, H., Visse, R. & Murphy, G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69, 562\u2013573 (2006).","journal-title":"Cardiovasc. Res."},{"key":"BFnm2582_CR8","doi-asserted-by":"publisher","first-page":"G175","DOI":"10.1152\/ajpgi.90454.2008","volume":"296","author":"P Garg","year":"2009","unstructured":"Garg, P. et al. Matrix metalloproteinase-9\u2013mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G175\u2013G184 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnm2582_CR9","doi-asserted-by":"publisher","first-page":"15353","DOI":"10.1074\/jbc.R800069200","volume":"284","author":"FX Gomis-R\u00fcth","year":"2009","unstructured":"Gomis-R\u00fcth, F.X. Catalytic domain architecture of metzincin metalloproteases. J. Biol. Chem. 284, 15353\u201315357 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnm2582_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0022-2836(02)00262-0","volume":"319","author":"S Rowsell","year":"2002","unstructured":"Rowsell, S. et al. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. J. Mol. Biol. 319, 173\u2013181 (2002).","journal-title":"J. Mol. Biol."},{"key":"BFnm2582_CR11","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.1073\/pnas.0407106102","volume":"102","author":"I Bertini","year":"2005","unstructured":"Bertini, I. et al. Conformational variability of matrix metalloproteinases: beyond a single 3D structure. Proc. Natl. Acad. Sci. USA 102, 5334\u20135339 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2582_CR12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1006\/jmbi.1996.0548","volume":"262","author":"RM MacCallum","year":"1996","unstructured":"MacCallum, R.M., Martin, A.C.R. & Thornton, J.M. Antibody-antigen interactions: contact analysis and binding site topography. J. Mol. Biol. 262, 732\u2013745 (1996).","journal-title":"J. Mol. Biol."},{"key":"BFnm2582_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/prot.20145","volume":"56","author":"A Berchanski","year":"2004","unstructured":"Berchanski, A., Shapira, B. & Eisenstein, M. Hydrophobic complementarity in protein-protein docking. Proteins 56, 130\u2013142 (2004).","journal-title":"Proteins"},{"key":"BFnm2582_CR14","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham, C. & Cho, J.H. Inflammatory bowel disease. N. Engl. J. Med. 361, 2066\u20132078 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2582_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.dld.2005.02.011","volume":"37","author":"Q Gao","year":"2005","unstructured":"Gao, Q. et al. Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases. Dig. Liver Dis. 37, 584\u2013592 (2005).","journal-title":"Dig. Liver Dis."},{"key":"BFnm2582_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/gut.2003.017442","volume":"53","author":"T Kirkegaard","year":"2004","unstructured":"Kirkegaard, T., Hansen, A., Bruun, E. & Brynskov, J. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease. Gut 53, 701\u2013709 (2004).","journal-title":"Gut"},{"key":"BFnm2582_CR17","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0016-5085(99)70339-2","volume":"117","author":"MD Baugh","year":"1999","unstructured":"Baugh, M.D. et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 117, 814\u2013822 (1999).","journal-title":"Gastroenterology"},{"key":"BFnm2582_CR18","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.3748\/wjg.v12.i40.6464","volume":"12","author":"A Santana","year":"2006","unstructured":"Santana, A. et al. Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice. World J. Gastroenterol. 12, 6464\u20136472 (2006).","journal-title":"World J. Gastroenterol."},{"key":"BFnm2582_CR19","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1053\/j.gastro.2005.09.017","volume":"129","author":"FE Castaneda","year":"2005","unstructured":"Castaneda, F.E. et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology 129, 1991\u20132008 (2005).","journal-title":"Gastroenterology"},{"key":"BFnm2582_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.mog.0000231808.10773.8e","volume":"22","author":"G Monteleone","year":"2006","unstructured":"Monteleone, G., Fina, D., Caruso, R. & Pallone, F. New mediators of immunity and inflammation in inflammatory bowel disease. Curr. Opin. Gastroenterol. 22, 361\u2013364 (2006).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"BFnm2582_CR21","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.4049\/jimmunol.177.6.4103","volume":"177","author":"P Garg","year":"2006","unstructured":"Garg, P. et al. Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis. J. Immunol. 177, 4103\u20134112 (2006).","journal-title":"J. Immunol."},{"key":"BFnm2582_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrd1986","volume":"5","author":"JR Korzenik","year":"2006","unstructured":"Korzenik, J.R. & Podolsky, D.K. Evolving knowledge and therapy of inflammatory bowel disease. Nat. Rev. Drug Discov. 5, 197\u2013209 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm2582_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mrm.22798","volume":"66","author":"T Aychek","year":"2011","unstructured":"Aychek, T., Vandoorne, K., Brenner, O., Jung, S. & Neeman, M. Quantitative analysis of intravenously administered contrast media reveals changes in vascular barrier functions in a murine colitis model. Magn. Reson. Med. 66, 235\u2013243 (2011).","journal-title":"Magn. Reson. Med."},{"key":"BFnm2582_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc1821","volume":"6","author":"CM Overall","year":"2006","unstructured":"Overall, C.M. & Kleifeld, O. Tumour microenvironment\u2014opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 6, 227\u2013239 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm2582_CR25","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1126\/science.1067100","volume":"295","author":"LM Coussens","year":"2002","unstructured":"Coussens, L.M., Fingleton, B. & Matrisian, L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387\u20132392 (2002).","journal-title":"Science"},{"key":"BFnm2582_CR26","doi-asserted-by":"publisher","first-page":"33992","DOI":"10.1074\/jbc.M504303200","volume":"280","author":"M Ikejiri","year":"2005","unstructured":"Ikejiri, M. et al. Potent mechanism-based inhibitors for matrix metalloproteinases. J. Biol. Chem. 280, 33992\u201334002 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnm2582_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/ATVBAHA.110.219147","volume":"31","author":"JL Johnson","year":"2011","unstructured":"Johnson, J.L. et al. A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Arterioscler. Thromb. Vasc. Biol. 31, 528\u2013535 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm2582_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1517\/17460441.2011.560936","volume":"6","author":"N Sela-Passwell","year":"2011","unstructured":"Sela-Passwell, N., Trahtenherts, A., Kr\u00fcger, A. & Sagi, I. New opportunities in drug design of metalloproteinase inhibitors: combination between structure-function experimental approaches and systems biology. Expert Opin. Drug Discov. 6, 527\u2013542 (2011).","journal-title":"Expert Opin. Drug Discov."},{"key":"BFnm2582_CR29","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.biochi.2010.07.017","volume":"92","author":"L Devel","year":"2010","unstructured":"Devel, L. et al. Third generation of matrix metalloprotease inhibitors: gain in selectivity by targeting the depth of the S1\u2032 cavity. Biochimie 92, 1501\u20131508 (2010).","journal-title":"Biochimie"},{"key":"BFnm2582_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ceb.2009.06.006","volume":"21","author":"CJ Morrison","year":"2009","unstructured":"Morrison, C.J., Butler, G.S., Rodriguez, D. & Overall, C.M. Matrix metalloproteinase proteomics: substrates, targets, and therapy. Curr. Opin. Cell Biol. 21, 645\u2013653 (2009).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnm2582_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bbamcr.2009.09.016","volume":"1803","author":"A Kr\u00fcger","year":"2010","unstructured":"Kr\u00fcger, A., Kates, R.E. & Edwards, D.R. Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition. Biochim. Biophys. Acta 1803, 95\u2013102 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnm2582_CR32","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1126\/science.284.5420.1667","volume":"284","author":"E Morgunova","year":"1999","unstructured":"Morgunova, E. et al. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 284, 1667\u20131670 (1999).","journal-title":"Science"},{"key":"BFnm2582_CR33","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1107\/S0907444902007849","volume":"58","author":"PA Elkins","year":"2002","unstructured":"Elkins, P.A. et al. Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. Acta Crystallogr. D Biol. Crystallogr. 58, 1182\u20131192 (2002).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnm2582_CR34","unstructured":"Harlow, E.D.P.L. Antibodies: A Laboratory Manual. Ch. 6 (Cold Spring Harbor Laboratory Press, 1998)."},{"key":"BFnm2582_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0014-5793(92)80300-6","volume":"296","author":"CG Knight","year":"1992","unstructured":"Knight, C.G., Willenbrock, F. & Murphy, G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296, 263\u2013266 (1992).","journal-title":"FEBS Lett."},{"key":"BFnm2582_CR36","doi-asserted-by":"publisher","first-page":"31646","DOI":"10.1074\/jbc.M401310200","volume":"279","author":"A Solomon","year":"2004","unstructured":"Solomon, A. et al. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-\u03b1\u2013converting enzyme and matrix metalloproteinases despite their high structural similarity. J. Biol. Chem. 279, 31646\u201331654 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm2582_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nprot.2007.41","volume":"2","author":"S Wirtz","year":"2007","unstructured":"Wirtz, S., Neufert, C., Weigmann, B. & Neurath, M.F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541\u2013546 (2007).","journal-title":"Nat. Protoc."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2582","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:29:57Z","timestamp":1684448997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFnm2582"],"URL":"https:\/\/doi.org\/10.1038\/nm.2582","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,25]]}}}